The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine
Phase 4
196
about 4 years
8–18
1 site in MA
What this study is about
Researchers are testing a treatment called Adderall XR (mixed salts amphetamine) to see if it helps people with ADHD and autism. The trial will last 1461 days, involving brain imaging scans at MIT. Participants will take either Adderall XR or a placebo for 10 weeks, completing questionnaires and virtual visits.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Adderall XR (mixed salts amphetamine)
- 2.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
stimulant (Amphetamine/dextroamphetamine (CNS stimulant combination)), NERVOUS SYSTEM
Secondary: Pre and post treatment changes in ASD core symptoms on Social Responsiveness Scale 2 (SRS-2)
Psychiatry / Mental Health